These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29550678)

  • 21. Small-size recombinant adenoviral hexon protein fragments for the production of virus-type specific antibodies.
    Pacesa M; Hendrickx R; Bieri M; Flatt JW; Greber UF; Hemmi S
    Virol J; 2017 Aug; 14(1):158. PubMed ID: 28821267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping the epitope of neutralizing monoclonal antibodies against human adenovirus type 3.
    Tian X; Liu M; Su X; Jiang Z; Ma Q; Liao X; Li X; Zhou Z; Li C; Zhou R
    Virus Res; 2015 Oct; 208():66-72. PubMed ID: 26071383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Humoral immune response to the capsid components of recombinant adenoviruses: routes of immunization modulate virus-induced Ig subclass shifts.
    Gahéry-Ségard H; Juillard V; Gaston J; Lengagne R; Pavirani A; Boulanger P; Guillet JG
    Eur J Immunol; 1997 Mar; 27(3):653-9. PubMed ID: 9079805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epitope mapping and cross-reactivity analysis of the monoclonal antibodies against hexon protein of human adenovirus type 3.
    Qiu H; Zhou Z; Feng K; Tian X; Li X; Li H; Xing K; Chen J; Li C; Zhou R
    Virus Res; 2009 Dec; 146(1-2):58-65. PubMed ID: 19732803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seroprevalence of Neutralizing Antibodies against Human Adenovirus Type-5 and Chimpanzee Adenovirus Type-68 in Cancer Patients.
    Zhao H; Xu C; Luo X; Wei F; Wang N; Shi H; Ren X
    Front Immunol; 2018; 9():335. PubMed ID: 29563911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Worldwide increased prevalence of human adenovirus type 3 (HAdV-3) respiratory infections is well correlated with heterogeneous hypervariable regions (HVRs) of hexon.
    Haque E; Banik U; Monowar T; Anthony L; Adhikary AK
    PLoS One; 2018; 13(3):e0194516. PubMed ID: 29590206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antipeptide antisera define neutralizing epitopes on the adenovirus hexon.
    Toogood CI; Crompton J; Hay RT
    J Gen Virol; 1992 Jun; 73 ( Pt 6)():1429-35. PubMed ID: 1376769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A humanized anti-human adenovirus 55 monoclonal antibody with good neutralization ability.
    Chen L; Lu J; Yue J; Wang R; Du P; Yu Y; Guo J; Wang X; Jiang Y; Cheng K; Yang Z; Zheng T
    Front Immunol; 2023; 14():1132822. PubMed ID: 37006289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Preparation of mouse monoclonal antibodies against human adenovirus 55 Hexon (HAdV55 Hexon) protein].
    Yuan R; Dong Y; Wu F; Duan T; Xue P; Zhang J; Yuan M; Xue Z; Zhang H; Zhang Q; Gao X; Lei Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Jun; 39(6):544-551. PubMed ID: 37340923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seroprevalence of neutralizing antibodies against adenovirus type 14 and 55 in healthy adults in Southern China.
    Zheng X; Rong X; Feng Y; Sun X; Li L; Wang Q; Wang M; Liu W; Li C; Yang Y; Zhou R; Lu J; Feng L; Chen L
    Emerg Microbes Infect; 2017 Jun; 6(6):e43. PubMed ID: 28588291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complement component C1q and anti-hexon antibody mediate adenovirus infection of a CAR-negative cell line.
    Tsai V; Varghese R; Ravindran S; Ralston R; Vellekamp G
    Viral Immunol; 2008 Dec; 21(4):469-76. PubMed ID: 19115936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity.
    Gahéry-Ségard H; Farace F; Godfrin D; Gaston J; Lengagne R; Tursz T; Boulanger P; Guillet JG
    J Virol; 1998 Mar; 72(3):2388-97. PubMed ID: 9499099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Penton base induces better protective immune responses than fiber and hexon as a subunit vaccine candidate against adenoviruses.
    Hu K; Fu M; Guan X; Zhang D; Deng X; Xiao Y; Chen R; Liu H; Hu Q
    Vaccine; 2018 Jul; 36(29):4287-4297. PubMed ID: 29885770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Preparation and characterization of specific monoclonal antibodies against hexon of HAdV 3].
    Zhou R; Sheng HY; Tian XG; Wang CB; Gong ST; Chen QL
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1008-10. PubMed ID: 18583250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of adenovirus hexons by their epitope composition.
    Adám E; Nász I; Lengyel A
    Arch Virol; 1996; 141(10):1891-907. PubMed ID: 8920823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased immune reactivity towards a knobless, affibody-targeted adenovirus type 5 vector.
    Myhre S; Henning P; Granio O; Tylö AS; Nygren PA; Olofsson S; Boulanger P; Lindholm L; Hong SS
    Gene Ther; 2007 Feb; 14(4):376-81. PubMed ID: 17036056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigenic variability among two subtypes of human adenovirus serotype 7.
    Tian X; Su X; Xue C; Li X; Zhou Z; Zhou R
    Virus Genes; 2014 Aug; 49(1):22-9. PubMed ID: 24760574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of malleability and immunological properties of human adenovirus type 3 hexon hypervariable region 1.
    Zhong T; Li X; Zhou Z; Li T; Tian X; Zhou R
    Arch Virol; 2012 Sep; 157(9):1709-18. PubMed ID: 22669318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutralizing and cross-neutralizing antibody titres induced by bivalent and quadrivalent human papillomavirus vaccines in the target population of organized vaccination programmes.
    Barzon L; Squarzon L; Masiero S; Pacenti M; Marcati G; Mantelli B; Gabrielli L; Pascucci MG; Lazzarotto T; Caputo A; Palù G
    Vaccine; 2014 Sep; 32(41):5357-62. PubMed ID: 25045814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Directed evolution of mutator adenoviruses resistant to antibody neutralization.
    Myers ND; Skorohodova KV; Gounder AP; Smith JG
    J Virol; 2013 May; 87(10):6047-50. PubMed ID: 23487468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.